The synthetic biology community is divided on intellectual property. – Slate Magazine
Slate Magazine |
The synthetic biology community is divided on intellectual property.
Slate Magazine As with many new fields, synthetic biology—which incorporates disparate disciplines like engineering, computer science, biotechnology, and molecular bi … Synthetic Biology Market to Exceed US$ 38 Billion Globally by 2020MilTech |
Spectrum |
Preprint peek-a-boo; vexing vacancy; CRISPR conundrum
Spectrum More and more biologists are posting their papers on preprint servers, making their findings public before they’ve been through the drawn-out process of peer review. Not all journal publishers welcomed this new culture of openness at first, but most … |
BioPharma-Reporter.com |
Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts
BioPharma-Reporter.com Such cells come from bone marrow, adipose tissue and umbilical cord blood but are very rare, according to Ana Fernandes-Platzgummer, a research scientist for the Stem Cell Engineering Research Group at the Instituto Superior Técnico in Lisbon, Portugal. Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round …PR Web (press release) |
BioPharma-Reporter.com |
Stem cells: Single-use bioreactors and microcarriers can overcome scale-up issues, experts
BioPharma-Reporter.com Such cells come from bone marrow, adipose tissue and umbilical cord blood but are very rare, according to Ana Fernandes-Platzgummer, a research scientist for the Stem Cell Engineering Research Group at the Instituto Superior Técnico in Lisbon, Portugal. Provia Laboratories, cGMP Autologous Stem Cell Company, Launches $2M Growth Capital Financing Round …PR Web (press release) |
|
Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around …
Business Wire (press release) To start off the symposium Dr. Dan MacLeod of Precision Biosciences described using the ARCUS gene editing technology to produce heterologous CAR-T cells which can be used across multiple patients. By using an xCELLigence® Real-Time Cell Analysis … |